AiKeXian ® -GutScrCombined detection for five major types of digestive system cancers
Significance of Testing: Regular testing increases the rate of early diagnosis and treatment, which is the most effective way to reduce mortality and medical burden associated with the five major digestive system cancers worldwide
Comprehensive
A single test covers the five most common types of digestive system cancers
Precision
Utilizing Al-based peptidomics technology for accurate cancer signal identification and precise tracing of the cancer's origin
Convenience
Only 3mL of venous blood sample required,
no fasting needed
Obtained the First Medical Device Registration Certificate for Clinically Researched Peptide or Protein Fingerprinting (Certificate No.: 浙械注准20242221307) in 2024
Chosen as the Only Product in the Mass Spectrometry Proteomics Field to be Listed on the MIIT's Artificial Intelligence Medical Device Innovation Task List in 2022
Included in the Key Technical Indicators List for the First (Set) of Major Areas in Zhejiang Province's Manufacturing Industry (High-End Medical Devices) in 2023
Received Support from Multiple Key Research and Development Projects
Selected as the Sole High-End Medical Equipment in the Engineering Development Key Projects of Zhejiang Province’s Manufacturing Industry's First (Set) Product in 2022
